The Renaissance
Johns Hopkins and MAPS, MDMA-assisted therapy for PTSD, Michael Pollan, Oregon and Colorado, ketamine clinics — psychedelics return to the laboratory and the clinic.
Part of Psychedelics
30 moments in this segment.
- — Johns Hopkins Psilocybin Research Project - Roland Griffiths. Roland Griffiths of Johns Hopkins.
- — Principles of MDMA-Assisted Psychotherapy for PTSD | MAPS. 's late-stage trials of MDMA-assisted psychotherapy for post-traumatic stress disorder.
- — Psilocybin & Spirituality - Roland Griffiths, Johns Hopkins. Roland Griffiths of Johns Hopkins.
- — Roland Griffiths: Psilocybin Research for Anxiety & Psychological Distress. The Johns Hopkins researcher whose rigorous psilocybin studies from 2006 reopened the door to legitimate psychedelic science.
- — Johns Hopkins Psilocybin Cancer Anxiety Study - Patient Interview. (2015).
- — The Science of Psilocybin and Its Use to Relieve Suffering | TEDMED. The Science of Psilocybin and Its Use to Relieve Suffering — Roland Griffiths of Johns Hopkins.
- — Roland Griffiths: Johns Hopkins Psilocybin Project - Implications for Spirituality & Therapeutics. Roland Griffiths of Johns Hopkins.
- — Stephen Ross & Gabby Agin-Liebes: Psilocybin for Cancer-Related Distress | MAPS. Stephen Ross & Gabby Agin-Liebes: Psilocybin for Cancer-Related Distress (2017).
- — The Future of Psychedelic-Assisted Psychotherapy | Rick Doblin | TED. The Future of Psychedelic-Assisted Psychotherapy — Rick Doblin, founder of MAPS.
- — Cancer Patient Overcomes Anxiety About Death with Psychedelics | 60 Minutes. Cancer Patient Overcomes Anxiety About Death with Psychedelics (2019).
- — Psychedelics Help a Cancer Patient Face Death | 60 Minutes. Psychedelics Help a Cancer Patient Face Death — The landmark trials giving psilocybin to patients facing terminal cancer — and easing their fear of death.
- — Rick Doblin: Transformational Psychedelics. Rick Doblin, founder of MAPS.
- — Psilocybin therapy (2020). ).
- — Oregon Measure 109 Explained | Oregon Public Broadcasting. Oregon Measure 109 Explained (2020).
- — Oregon Voters Approve Measure 109, Psilocybin for Therapy. (2020).
- — MDMA-Assisted Therapy for PTSD | Stanford Psychedelic Science. MDMA-Assisted Therapy for PTSD (2021).
- — How Ketamine Treats Depression - Yale Medicine Explains. (2021).
- — Can Ayahuasca Treat Depression? - Dr Palhano-Fontes | Drug Science. Can Ayahuasca Treat Depression? - Dr Palhano-Fontes (2021).
- — How to Change Your Mind | Official Trailer | Netflix. How to Change Your Mind (2022).
- — MDMA-Assisted Therapy for PTSD: Phase 3, Europe, and Beyond. (2022).
- — The Science of MDMA Therapy | With MAPS Founder Rick Doblin. The Science of MDMA Therapy — Founder of MAPS, who spent decades shepherding MDMA-assisted therapy for PTSD toward FDA approval.
- — Johns Hopkins Psychiatry Rounds | Psilocybin Research for Suffering. Johns Hopkins Psychiatry Rounds (2023).
- — Investigational MDMA-Assisted Therapy for PTSD: Phase 3 Data. (2023).
- — How Psychedelics Are Helping Families and Veterans Heal | CBS Mornings. How Psychedelics Are Helping Families and Veterans Heal (2023).
- — A Woman's Journey: Clinical Treatment with Psilocybin | Johns Hopkins. A Woman's Journey: Clinical Treatment with Psilocybin (2024).
- — U.S. Veterans with PTSD Take a Psychedelic Journey in Mexico | 60 Minutes. U.S. Veterans with PTSD Take a Psychedelic Journey in Mexico (2025).
- — Psychedelics and Other Unconventional Therapies | 60 Minutes. Psychedelics and Other Unconventional Therapies (2025).
- — Dr Bill Richards: Psychedelics and Sacred Knowledge. (2025).
- — Johns Hopkins Psychiatry Grand Rounds | Psilocybin Research. Johns Hopkins Psychiatry Grand Rounds — The university lab whose trials for depression, addiction and end-of-life anxiety anchor the modern renaissance.
- — Is Ketamine Revolutionizing the Treatment of Depression? | TVO Today. Is Ketamine Revolutionizing the Treatment of Depression? (2025).
